Correction to: Analysis of autonomic outcomes in APOLLO, a phase III trial of the RNAi therapeutic patisiran in patients with hereditary transthyretin-mediated amyloidosis

The original version of this article unfortunately contained a mistake.

Source: Journal of Neurology - February 6, 2020 Category: Neurology Source Type: research